Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Azam Bolhassani

Showing results (121-130 of 176) with videos related to

Pageof 18
Sort By:
Protein and Peptide Letters|January 4, 2021
HIV-1 Accessory Proteins: Which one is Potentially Effective in Diagnosis and Vaccine Development?Alireza Milani, Kazem Baesi, Elnaz Agi, et al.
Microbial Pathogenesis|January 10, 2026
Enhancement of the efficiency of a DNA vaccine construct harboring HSP70 mini-chaperones linked to HIV-1 Nef antigen using IL-7 cytokine and REV peptideNeda Tajvidi, Azam Bolhassani, Masoumeh Heshmati, et al.
Hematology (Amsterdam, Netherlands)|July 12, 2018
Polymorphisms in the TGF-β1 (rs1982037) and IL-2 (rs2069762, rs4833248) genes are not associated with inhibitor development in Iranian patients with hemophilia ANiloofar Naderi, Fariba Ebrahimzadeh, Mohammad Jazebi, et al.
Protein and Peptide Letters|December 22, 2016
Immuno-Stimulating Peptide Derived from HMGB1 is More Effective Than the N-Terminal Domain of Gp96 as an Endogenous Adjuvant for Improvement of Protein VaccinesSomayeh Talebi, Azam Bolhassani, Talat M Azad, et al.
Molecular Immunology|February 26, 2019
Modified DCs and MSCs with HPV E7 antigen and small Hsps: Which one is the most potent strategy for eradication of tumors?Azam Bolhassani, Sepideh Shahbazi, Elnaz Agi, et al.
Protein and Peptide Letters|November 19, 2024
Comparative Analysis of IMT-P8 and LDP12 Cell-Penetrating Peptides in Increasing Immunostimulatory Properties of HIV-1 Nef-MPER-V3 AntigenSeyed Mehdi Sadat, Shekoufa Jahedian, Sahar Sabaghzadeh, et al.
Current HIV Research|March 8, 2019
Induction of a Robust Humoral Response using HIV-1 VLP<sup>MPER-V3</sup> as a Novel Candidate Vaccine in BALB/c MiceFatemeh Tohidi, Seyed Mehdi Sadat, Azam Bolhassani, et al.
The Indian Journal of Medical Research|January 22, 2010
Antibody detection against HPV16 E7 & GP96 fragments as biomarkers in cervical cancer patientsAzam Bolhassani, Farnaz Zahedifard, Yasaman Taslimi, et al.
Immunology Letters|October 23, 2012
Different domains of glycoprotein 96 influence HPV16 E7 DNA vaccine potency via electroporation mediated delivery in tumor mice modelAmin Daemi, Azam Bolhassani, Sima Rafati, et al.
International Journal of Biological Macromolecules|May 20, 2024
Engineered dendritic cells-derived exosomes harboring HIV-1 Nef<sup>mut</sup>-Tat fusion protein and heat shock protein 70: A promising HIV-1 safe vaccine candidateParisa Moradi Pordanjani, Azam Bolhassani, Mohammad Hassan Pouriayevali, et al.
Pageof 18

Showing results (121-130 of 176) with videos related to

Sort By:
Pageof 18
Protein and Peptide Letters|January 4, 2021
HIV-1 Accessory Proteins: Which one is Potentially Effective in Diagnosis and Vaccine Development?Alireza Milani, Kazem Baesi, Elnaz Agi, et al.
Microbial Pathogenesis|January 10, 2026
Enhancement of the efficiency of a DNA vaccine construct harboring HSP70 mini-chaperones linked to HIV-1 Nef antigen using IL-7 cytokine and REV peptideNeda Tajvidi, Azam Bolhassani, Masoumeh Heshmati, et al.
Hematology (Amsterdam, Netherlands)|July 12, 2018
Polymorphisms in the TGF-β1 (rs1982037) and IL-2 (rs2069762, rs4833248) genes are not associated with inhibitor development in Iranian patients with hemophilia ANiloofar Naderi, Fariba Ebrahimzadeh, Mohammad Jazebi, et al.
Protein and Peptide Letters|December 22, 2016
Immuno-Stimulating Peptide Derived from HMGB1 is More Effective Than the N-Terminal Domain of Gp96 as an Endogenous Adjuvant for Improvement of Protein VaccinesSomayeh Talebi, Azam Bolhassani, Talat M Azad, et al.
Molecular Immunology|February 26, 2019
Modified DCs and MSCs with HPV E7 antigen and small Hsps: Which one is the most potent strategy for eradication of tumors?Azam Bolhassani, Sepideh Shahbazi, Elnaz Agi, et al.
Protein and Peptide Letters|November 19, 2024
Comparative Analysis of IMT-P8 and LDP12 Cell-Penetrating Peptides in Increasing Immunostimulatory Properties of HIV-1 Nef-MPER-V3 AntigenSeyed Mehdi Sadat, Shekoufa Jahedian, Sahar Sabaghzadeh, et al.
Current HIV Research|March 8, 2019
Induction of a Robust Humoral Response using HIV-1 VLP<sup>MPER-V3</sup> as a Novel Candidate Vaccine in BALB/c MiceFatemeh Tohidi, Seyed Mehdi Sadat, Azam Bolhassani, et al.
The Indian Journal of Medical Research|January 22, 2010
Antibody detection against HPV16 E7 & GP96 fragments as biomarkers in cervical cancer patientsAzam Bolhassani, Farnaz Zahedifard, Yasaman Taslimi, et al.
Immunology Letters|October 23, 2012
Different domains of glycoprotein 96 influence HPV16 E7 DNA vaccine potency via electroporation mediated delivery in tumor mice modelAmin Daemi, Azam Bolhassani, Sima Rafati, et al.
International Journal of Biological Macromolecules|May 20, 2024
Engineered dendritic cells-derived exosomes harboring HIV-1 Nef<sup>mut</sup>-Tat fusion protein and heat shock protein 70: A promising HIV-1 safe vaccine candidateParisa Moradi Pordanjani, Azam Bolhassani, Mohammad Hassan Pouriayevali, et al.
Pageof 18